Christopher Svendsen Associate Litigation Christopher represents technology and life sciences companies in a broad range of patent litigation matters.
Blog Will the Supreme Court Review Whether FDA-Mandated Bioequivalence Testing to Maintain Approval Falls Within the § 271(e)(1) Safe Harbor? August 15, 2016
Video What's More Concerning, A Whistleblower or Your Response? Find Out What the SEC Thinks August 11, 2016
